| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.06B | 16.87B | 22.27B | 14.28B | 26.69B |
| Gross Profit | 6.45B | 5.10B | 6.98B | 4.09B | 6.84B |
| EBITDA | 5.45B | 4.16B | 6.58B | 3.01B | 5.68B |
| Net Income | 1.75B | 1.42B | 3.19B | 1.18B | 2.80B |
Balance Sheet | |||||
| Total Assets | 89.83B | 89.14B | 89.94B | 87.64B | 82.55B |
| Cash, Cash Equivalents and Short-Term Investments | 7.93B | 5.32B | 8.16B | 7.64B | 11.11B |
| Total Debt | 56.48B | 58.18B | 58.45B | 59.23B | 53.15B |
| Total Liabilities | 63.58B | 64.23B | 65.51B | 66.00B | 61.74B |
| Stockholders Equity | 26.14B | 24.80B | 24.32B | 21.54B | 20.71B |
Cash Flow | |||||
| Free Cash Flow | 3.68B | -1.31B | 1.24B | -7.13B | 292.20M |
| Operating Cash Flow | 7.24B | 3.50B | 3.21B | -4.57B | 301.18M |
| Investing Cash Flow | -3.05B | -4.24B | -1.58B | -3.15B | -399.76M |
| Financing Cash Flow | -2.33B | -1.19B | -1.21B | 4.29B | 4.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥62.18B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
76 Outperform | ¥48.70B | 7.03 | 6.18% | 4.42% | 1.56% | -9.90% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥119.38B | 8.60 | 5.11% | 5.07% | -19.64% | -31.08% | |
63 Neutral | ¥17.21B | 9.36 | ― | 2.86% | 36.31% | 52.62% | |
44 Neutral | ¥16.98B | -12.65 | ― | ― | -21.88% | 17.12% | |
44 Neutral | ¥20.60B | 169.87 | ― | 1.85% | -40.77% | -91.81% |